{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:31:52Z","timestamp":1790652712610,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.iac.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T01:45:39Z","timestamp":1502329539000},"page":"629-641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Drug-Induced Anaphylaxis"],"prefix":"10.1016","volume":"37","author":[{"given":"Marcelo Vivolo","family":"Aun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Giavina-Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.iac.2017.06.002_bib1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization","volume":"113","author":"Johansson","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2017.06.002_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1939-4551-7-9","article-title":"International consensus on (ICON) anaphylaxis","volume":"7","author":"Simons","year":"2014","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.iac.2017.06.002_bib4","first-page":"40","article-title":"Drug-induced anaphylaxis survey in Portuguese Allergy Departments","volume":"24","author":"Faria","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2017.06.002_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.anai.2016.10.025","article-title":"Epidemiology of anaphylaxis at a tertiary care center: a report of 730 cases","volume":"118","author":"Gonzalez-Estrada","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2017.06.002_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ J"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2013Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"WAO Position Paper. World allergy organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"World Allergy Organ J"},{"issue":"3","key":"10.1016\/j.iac.2017.06.002_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jaip.2015.03.015","article-title":"Anaphylaxis after hymenoptera sting: is it venom allergy, a clonal disorder, or both?","volume":"3","author":"Castells","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.iac.2014.01.014","article-title":"Drug allergy in mastocytosis","volume":"34","author":"Bonadonna","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib11","first-page":"262","article-title":"Anaphylaxis: a ten years inpatient retrospective study","volume":"28","author":"Techapornroong","year":"2010","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/ACI.0b013e32832db95a","article-title":"Epidemiology of anaphylaxis","volume":"9","author":"Tang","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2017.06.002_bib13","doi-asserted-by":"crossref","first-page":"e5750","DOI":"10.1097\/MD.0000000000005750","article-title":"True rise in anaphylaxis incidence: epidemiologic study based on a national health insurance database","volume":"96","author":"Yang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2008.10.049","article-title":"Anaphylaxis fatalities and admissions in Australia","volume":"123","author":"Liew","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2017.06.002_bib15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.iac.2017.06.002_bib16","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1046\/j.1365-2222.1996.d01-300.x","article-title":"Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974-1994) and review of the literature","volume":"26","author":"van der Klauw","year":"1996","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/(SICI)1099-1557(199807\/08)7:4<269::AID-PDS366>3.0.CO;2-3","article-title":"Drug-attributed anaphylaxis","volume":"7","author":"Wang","year":"1998","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.iac.2017.06.002_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00002018-200528060-00006","article-title":"Drug-induced anaphylaxis: case\/non-case study based on an Italian pharmacovigilance database","volume":"28","author":"Leone","year":"2005","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaip.2014.03.014","article-title":"Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis","volume":"2","author":"Aun","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.iac.2017.06.002_bib20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/all.12168","article-title":"Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010","volume":"68","author":"Renaudin","year":"2013","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2017.06.002_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00228-012-1376-5","article-title":"Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority","volume":"69","author":"Ribeiro-Vaz","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaip.2014.08.016","article-title":"Drug-induced anaphylaxis in children: nonsteroidal anti-inflammatory drugs and drug provocation test","volume":"2","author":"Ensina","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaip.2014.08.015","article-title":"Reply: to PMID 25017529","volume":"2","author":"Aun","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.iac.2017.06.002_bib24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaip.2015.05.012","article-title":"Drug-induced anaphylaxis in Latin American countries","volume":"3","author":"Jares","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2017.06.002_bib25","article-title":"Epidemiology of anaphylaxis: a retrospective cohort study in Taiwan","author":"Lee","year":"2017","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"10.1016\/j.iac.2017.06.002_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.alit.2017.02.008","article-title":"Epidemiology of drug-induced anaphylaxis in a tertiary hospital in Korea","author":"Park","year":"2017","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.iac.2017.06.002_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/all.13006","article-title":"Decreasing the undernotification of anaphylaxis deaths in Brazil through the International Classification of Diseases (ICD)-11 revision","volume":"72","author":"Tanno","year":"2017","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.iac.2017.06.002_bib28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1398-9995.2011.02557.x","article-title":"Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs): classification, diagnosis and management: review of the EAACI\/ENDA and GA2LEN\/HANNA","volume":"66","author":"Kowalski","year":"2011","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.iac.2015.01.008","article-title":"Anaphylaxis to drugs","volume":"35","author":"Kuruvilla","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.iac.2017.06.002_bib30","series-title":"Anaphylaxis and hypersensitivity reactions","first-page":"1","article-title":"Definition and criteria for the diagnoses of anaphylaxis","author":"Lieberman","year":"2011"},{"key":"10.1016\/j.iac.2017.06.002_bib31","series-title":"Anaphylaxis and hypersensitivity reactions","first-page":"33","article-title":"Pathophysiology and organ damage in anaphylaxis","author":"Kemp","year":"2011"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.18176\/jiaci.0046","article-title":"Mechanisms of anaphylaxis beyond IgE","volume":"26","author":"Mu\u00f1oz-Cano","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"23","key":"10.1016\/j.iac.2017.06.002_bib33","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","volume":"358","author":"Kishimoto","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.iac.2017.06.002_bib34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.rmed.2013.03.014","article-title":"Non-steroidal anti-inflammatory drug hypersensitivity in adults and the factors associated with asthma","volume":"107","author":"Karakaya","year":"2013","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/ACI.0000000000000292","article-title":"Angioedema associated with nonsteroidal anti-inflammatory drugs","volume":"16","author":"Giavina-Bianchi","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.06.002_bib36","series-title":"NSAIDs (including aspirin): allergic and pseudoallergic reactions","author":"Simon","year":"2017"},{"issue":"7542","key":"10.1016\/j.iac.2017.06.002_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.iac.2017.06.002_bib38","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","article-title":"Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases","volume":"138","author":"Subramanian","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.06.002_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40268-017-0176-x","article-title":"In\u00a0vitro diagnosis of immediate drug hypersensitivity Anno 2017: potentials and limitations","volume":"17","author":"Decuyper","year":"2017","journal-title":"Drugs R D"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2010.02460.x","article-title":"In\u00a0vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones","volume":"66","author":"Aranda","year":"2011","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.iac.2017.06.002_bib41","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/cea.12140","article-title":"Advanced phenotyping in hypersensitivity drug reactions to NSAIDs","volume":"43","author":"Ayso","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.iac.2017.06.002_bib42","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaip.2016.11.006","article-title":"Basophil activation test is a relevant biomarker of the outcome of rapid desensitization in platinum compounds-allergy","volume":"5","author":"Giavina-Bianchi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11882-015-0515-3","article-title":"Presentation and diagnosis of hypersensitivity to platinum drugs","volume":"15","author":"Caiado","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.iac.2017.06.002_bib44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jaip.2017.03.015","article-title":"Immediate hypersensitivity reaction to chemotherapeutic agents","volume":"5","author":"Giavina-Bianchi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib45","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaci.2015.10.039","article-title":"Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions","volume":"137","author":"Picard","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib46","first-page":"170","article-title":"Immunoglobulin E-mediated severe anaphylaxis to paclitaxel","volume":"20","author":"Prieto Garcia","year":"2010","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaip.2014.12.006","article-title":"Hypersensitivity to biological agents-updated diagnosis, management, and treatment","volume":"3","author":"Galv\u00e3o","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2017.06.002_bib48","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment","volume":"124","author":"Brennan","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2017.06.002_bib49","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaip.2016.12.001","article-title":"Current knowledge and management of hypersensitivity reactions to monoclonal antibodies","volume":"5","author":"Picard","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2017.06.002_bib50","first-page":"173","article-title":"Latex allergy","volume":"20","author":"Gaspar","year":"2012","journal-title":"Rev Port Imunoalergologia"},{"issue":"8","key":"10.1016\/j.iac.2017.06.002_bib51","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11882-014-0452-6","article-title":"Perioperative anaphylaxis","volume":"14","author":"Galv\u00e3o","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"10.1016\/j.iac.2017.06.002_bib52","first-page":"442","article-title":"Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice","volume":"21","author":"Mertes","year":"2011","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4168\/aair.2014.6.2.156","article-title":"Cross-reactivity to acetaminophen and celecoxib according to the type of nonsteroidal anti-inflammatory drug hypersensitivity","volume":"6","author":"Kim","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"issue":"2","key":"10.1016\/j.iac.2017.06.002_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/cei.12424","article-title":"Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase","volume":"178","author":"Krishna","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.iac.2017.06.002_bib55","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"ENDA\/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs - an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.iac.2017.06.002_bib56","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2017.06.002_bib57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2500\/aap.2011.32.3450","article-title":"Outcomes and safety of drug provocation tests","volume":"32","author":"Aun","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2017.06.002_bib58","series-title":"Anaphylaxis and hypersensitivity reactions","first-page":"13","article-title":"An epidemiological approach to reducing the risk of fatal anaphylaxis","author":"Pumphrey","year":"2011"},{"issue":"1","key":"10.1016\/j.iac.2017.06.002_bib59","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaip.2014.06.007","article-title":"Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine","volume":"3","author":"Campbell","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2017.06.002_bib60","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaip.2017.03.016","article-title":"Current knowledge and management of hypersensitivity to perioperative drugs and radiocontrast media","volume":"5","author":"Hsu Blatman","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2017.06.002_bib61","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s40521-015-0060-2","article-title":"Rapid desensitization in immediate hypersensitivity reaction to drugs","volume":"2","author":"Giavina-Bianchi","year":"2015","journal-title":"Curr Treat Options Allergy"},{"issue":"45","key":"10.1016\/j.iac.2017.06.002_bib62","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.2174\/1381612822666161025154506","article-title":"Desensitization for drug hypersensitivity to chemotherapy and monoclonal antibodies","volume":"22","author":"Bonamichi-Santos","year":"2016","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.iac.2017.06.002_bib63","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaip.2015.12.019","article-title":"Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies","volume":"4","author":"Sloane","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856117300632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856117300632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T03:52:25Z","timestamp":1719373945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856117300632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0889856117300632"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2017.06.002","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Induced Anaphylaxis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}